These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33375370)

  • 1. Finely-Tuned Calcium Oscillations in Osteoclast Differentiation and Bone Resorption.
    Okada H; Okabe K; Tanaka S
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmalemmal interface for calcium signaling in osteoclast differentiation.
    Okada H; Tanaka S
    Curr Opin Cell Biol; 2022 Feb; 74():55-61. PubMed ID: 35144107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium signaling in osteoclast differentiation and bone resorption.
    Kajiya H
    Adv Exp Med Biol; 2012; 740():917-32. PubMed ID: 22453976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic insight into osteoclast differentiation in osteoimmunology.
    Takayanagi H
    J Mol Med (Berl); 2005 Mar; 83(3):170-9. PubMed ID: 15776286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.
    Koga T; Inui M; Inoue K; Kim S; Suematsu A; Kobayashi E; Iwata T; Ohnishi H; Matozaki T; Kodama T; Taniguchi T; Takayanagi H; Takai T
    Nature; 2004 Apr; 428(6984):758-63. PubMed ID: 15085135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orai1-mediated calcium entry plays a critical role in osteoclast differentiation and function by regulating activation of the transcription factor NFATc1.
    Hwang SY; Putney JW
    FASEB J; 2012 Apr; 26(4):1484-92. PubMed ID: 22198385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RANKL-induced TRPV2 expression regulates osteoclastogenesis via calcium oscillations.
    Kajiya H; Okamoto F; Nemoto T; Kimachi K; Toh-Goto K; Nakayana S; Okabe K
    Cell Calcium; 2010 Nov; 48(5):260-9. PubMed ID: 20980052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation.
    Zawawi MS; Dharmapatni AA; Cantley MD; McHugh KP; Haynes DR; Crotti TN
    Biochem Biophys Res Commun; 2012 Oct; 427(2):404-9. PubMed ID: 23000414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomal Ca
    Erkhembaatar M; Gu DR; Lee SH; Yang YM; Park S; Muallem S; Shin DM; Kim MS
    J Bone Miner Res; 2017 Feb; 32(2):385-396. PubMed ID: 27589205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flunarizine inhibits osteoclastogenesis by regulating calcium signaling and promotes osteogenesis.
    Kim HJ; Lee J; Lee GR; Kim N; Lee HI; Kwon M; Kim NY; Park JH; Kang YH; Song HJ; Kim T; Shin DM; Jeong W
    J Cell Physiol; 2021 Dec; 236(12):8239-8252. PubMed ID: 34192358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.
    Humphrey MB; Nakamura MC
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):48-58. PubMed ID: 26573914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel osteoclast signaling mechanisms.
    Shinohara M; Takayanagi H
    Curr Osteoporos Rep; 2007 Jun; 5(2):67-72. PubMed ID: 17521508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro.
    Yang S; Li YP
    J Bone Miner Res; 2007 Jan; 22(1):45-54. PubMed ID: 17042716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANKL-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis.
    Kim MS; Yang YM; Son A; Tian YS; Lee SI; Kang SW; Muallem S; Shin DM
    J Biol Chem; 2010 Mar; 285(10):6913-21. PubMed ID: 20048168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca
    Cao B; Dai X; Wang W
    J Cell Physiol; 2019 May; 234(5):6831-6841. PubMed ID: 30387123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase C-related, but catalytically inactive protein (PRIP) up-regulates osteoclast differentiation via calcium-calcineurin-NFATc1 signaling.
    Murakami A; Matsuda M; Harada Y; Hirata M
    J Biol Chem; 2017 May; 292(19):7994-8006. PubMed ID: 28341745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.